#EHA25: Schrödinger reports early Phase 1 data for MALT1 inhibitor
Schrödinger said its experimental MALT1 inhibitor showed early signs of safety and efficacy in an ongoing Phase 1 trial. The company also said the data support its broader computational discovery platform, which allowed the team ...
Schrödinger said its experimental MALT1 inhibitor showed early signs of safety and efficacy in an ongoing Phase 1 trial.
The company also said the data support its broader computational discovery platform, which allowed the team ...
